Psychotic and behavioural abnormalities are common in dementia. Typical neuroleptics are extensively used for such disorders. Their use is attended with several severe side effects (McKeith et al.,1992) . It was noted that the experience with atypical antipsychotics, which have lesser adverse effects, for treatment of agitation and other behavioural problems in the demented elderly patients is extremely limited (Mintzer&Brawman-Mintzer, 1996) . Neuroleptic sensitivity has been reported in the use of atypical neuroleptic like risperidone in dementia patients but not with clozapine (McKeith et al.,1995; Ballard eta!., 1998) It seems that among the newer atypical antipsychotics, clozapine is probably more safe for use in dementia.
Clozapine was used effectively by the author in small doses for four patients of dementia with severe psychiatric symptoms and is reported here. The observation was made in four patients who presented with picture of dementia of a subacute/chronic nature and more recent psychiatric disturbances. Three of them were elderly patients with a clinical diagnosis of dementia of Alzheimer's type and one was a younger patient suffering from alcoholic dementia. The psychiatric symptoms consisted of insomnia, refusing to eat food, restlessness, wandering, shouting, abusive talk, irrelevant talk, hitting oneself, paranoid delusions, hallucinations and disinhibited behaviour.
Clozapine was given in doses ranging from 12.5 mg to 50 mg per day and the duration of treatment ranged from 2 months to six months. The necessary evaluation and monitoring of the haemogram was done as required, The starting of response to clozapine was immediate in all the patients. The commonly featunng symptoms of insomnia and loud talk improved after the first dose of the drug. Most of the other behavioural problems remitted fully in 4 to 6 weeks period. The overall degree of improvement in the clinical picture was rated as moderate to marked by the family members on a visual analog scale for three patients and as mild for one patient. Clozapine was discontinued for one of the patients after 2 months as she was feeling very drowsy and it "was replaced by bedtime dose of 25 mg of thioridazine.
Clozapine in low doses thus could be an effective and safe alternative to typical neuroleptics for controlling severe psychiatric manifestations in dementia patients The advantage of clozapine lies in its reduced risk for developing tardive dyskinesia and cognitive dysfunction, especially for the aged patients. With the necessary precautions the drug could be considered for use for severe psychiatric symptoms in dementia in selected subjects where other drugs were ineffective or caused severe adverse effects.
